[Radiolabelled peptides in the diagnosis and therapy of tumours].
In the last two decades, radiolabelled receptor-specific peptides have profiled themselves as excellent tools that have expressively increased the diagnostic and therapeutical possibilities of tumours predominantly of neuroendocrine origin. The aim of this review paper is to transparently inform the Czech scientific fraternity about the significance and limitations of the use of this group of radiopharmaceuticals in clinical practice.
Cihlo
J
J
Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové, Katedra farmakologie a toxikologie.
Láznícek
M
M
D006801:Humans; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D009479:Neuropeptides; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000627:therapeutic use*
D009479:Neuropeptides; D019275:Radiopharmaceuticals